RELATIVITY-020: Intracranial (IC) activity of nivolumab + relatlimab (NIVO + RELA) in patients (pts) with PD-(L)1 refractory melanoma with melanoma brain metastases (MBM).

Authors: Hussein A. Tawbi, F. Stephen Hodi, Evan J. Lipson, Eva Muñoz Couselo, James Larkin, Caroline Gaudy-Marqueste, Luke Mantle, Mark Semaan, Julius Strauss, Ruiyun Jiang, Diederik J. Grootendorst, Divya Patel, Paolo Antonio Ascierto

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.9525

Source: Full article

---

Abstract

9525